Hims & Hers Health is trading 7.25% down now at €25.58 after multiple law firms announced investigations into potential securities-law violations on August 26, 2026.
- Visa reportedly placed the company in a monitoring program after increased weight-loss subscription chargebacks, potentially triggering nearly $75,000 in September fees.
- Major U.S. indexes were broadly flat, while the stock remained volatile after its August 10 earnings release and subsequent payment-dispute reports.